Explore how a science-driven, phase-appropriate E&L strategy can help protect patient safety, improve operational efficiency and support innovation in new modality manufacturing.
Explore how a science-driven, phase-appropriate E&L strategy can help protect patient safety, improve operational efficiency and support innovation in new modality manufacturing.
Resource Type
samsung-listing.png
Landing Page Url
Byline
Sponsored By: Samsung Biologics